Advertisement
U.S. Markets closed

Oxford BioDynamics PLC (LMQ.BE)

Berlin - Berlin Delayed Price. Currency in EUR
0.01550.0000 (0.00%)
At close: 06:27PM CET
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
510
510
154
341
456
Cost of Revenue
244
244
38
0
622
Gross Profit
266
266
116
341
-166
Operating Expense
10,434
10,434
8,717
7,853
4,785
Operating Income
-10,168
-10,168
-8,601
-7,512
-4,951
Net Non Operating Interest Income Expense
-141
-141
-184
-83
102
Pretax Income
-11,411
-11,411
-7,567
-7,629
-4,946
Tax Provision
-585
-585
-857
-947
-597
Net Income Common Stockholders
-10,826
-10,826
-6,710
-6,682
-4,349
Diluted NI Available to Com Stockholders
-10,826
-10,826
-6,710
-6,682
-4,349
Basic EPS
-0.07
-0.07
-0.07
-0.07
-0.05
Diluted EPS
-0.07
-0.07
-0.07
-0.07
-0.05
Basic Average Shares
119,726
147,482
99,702
92,560
92,558
Diluted Average Shares
119,726
147,482
99,702
92,560
92,558
Total Operating Income as Reported
-10,168
-10,168
-8,601
-7,512
-4,951
Rent Expense Supplemental
-
-
-
-
38
Total Expenses
10,678
10,678
8,755
7,853
5,407
Net Income from Continuing & Discontinued Operation
-10,826
-10,826
-6,710
-6,682
-4,349
Normalized Income
-9,751
-9,751
-7,681
-6,682
-4,349
Interest Income
72
72
11
31
121
Interest Expense
213
213
195
114
19
Net Interest Income
-141
-141
-184
-83
102
EBIT
-11,198
-11,198
-7,372
-7,515
-4,927
EBITDA
-9,841
-9,841
-6,159
-6,427
-4,460
Reconciled Cost of Revenue
244
244
38
0
622
Reconciled Depreciation
1,357
1,357
1,213
1,088
467
Net Income from Continuing Operation Net Minority Interest
-10,826
-10,826
-6,710
-6,682
-4,349
Total Unusual Items Excluding Goodwill
-1,133
-1,133
1,095
0
-
Total Unusual Items
-1,133
-1,133
1,095
0
-
Normalized EBITDA
-8,708
-8,708
-7,254
-6,427
-4,460
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-58.0847
-58.0847
124.0141
0
0